Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Working arrangements after cancer diagnosis: who, what, when and how?

Date

22 Oct 2018

Session

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

Presenters

Caroline Alleaume

Citation

Annals of Oncology (2018) 29 (suppl_8): viii562-viii575. 10.1093/annonc/mdy297

Authors

C. Alleaume1, A. Bouhnik1, M.K. Bendiane2, P. Peretti-Watel2

Author affiliations

  • 1 Faculté De Médecine, Aix Marseille Univ, INSERM, IRD, Economics and Social Sciences Applied to Health & Analysis of Medical Information (SESSTIM), 13005 - Marseille/FR
  • 2 Faculté De Médecine, Aix Marseille Univ, INSERM, IRD, Economics and Social Sciences Applied to Health & Analysis of Medical Information (SESSTIM), 13006 - Marseille/FR
More

Resources

Background

Each year, 355,000 new individuals are diagnosed with cancer in France, nearly half of them being in working age and interrupting their professional occupation during treatments. As having working arrangements has been found to facilitate return to work after a long absence, it is provided by French law. This study aims to describe the use of working arrangements and to investigate how it is related to job retention.

Methods

This study combines analyses of quantitative and qualitative data: 1) VICAN5, a national representative survey on living conditions 5 years after cancer diagnosis conducted in 2015-2016 (n = 4,174), and 2) CAREMAJOB, a qualitative longitudinal study carried out in 2017 among patients on sick leave after a cancer diagnosis and interviewed about the impact of the disease on their working lives (n = 21). VICAN5 survey presents an overview about the use of working arrangements in France and the CAREMAJOB survey completes these results by giving the patients’ point of view in a more comprehensive manner.

Results

Among the 1,854 cancer survivors aged between 23 and 59 at time of the VICAN survey, and who were employed at diagnosis, 62.7% used working arrangement(s) within the five years following diagnosis. Nearly half of them (45.5%) had a working time arrangement. The other kind of working changes were about working hours (38.8%), working conditions (35.8%), occupation (32.8%), workplace (20.4%), and security at work (19.2%). Moreover, working arrangements are associated with job retention (88.9% of workers with working arrangement were still employed five years after diagnosis versus 69.6% of others). Furthermore, in CAREMAJOB survey, when patient returned to work without any working arrangement, this led to bad experience because of workload. However, some of those who did have an arrangement reported a negative impact on their professional life: they felt discriminated or thought that it has affected their professional credibility.

Conclusions

In the French context, the use of working arrangement seems to be a good factor to enhance job retention. National surveys should however better take into account the context of the implementation of working arrangement to get better understanding of the potential selection bias.

Clinical trial identification

Legal entity responsible for the study

INSERM, UMR_S 1252, « Sciences Economiques & Sociales de la Santé et Traitement de l\'Information Médicale » (SESSTIM).

Funding

Canceropole PACA Institut National du Cancer (INCA).

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

VOYAGER: An open-label, randomised, Phase 3 study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST)

Presenter: Sebastian Bauer

Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

Resources:

Abstract

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings